Boron compound from Anacor prepares for Phase III psoriasis trials
30 June 2011
Pial Ganguli
Please Login to read the full article.
30 June 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Ventrus gains on PhIII anal fissures data for diltiazem cream; awaits possible replication of EU study
- Neurocrine to begin Phase IIb of tardive dyskinesia drug despite 'inconsistencies'
- Medivir reveals final ASPIRE data for hep C protease inhibitor
- New data bolster Stelara's case for shift to first-line psoriasis treatment
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
